METTL3 and gastric cancer: Taken together, these results indicated that METTL3 might participate in metabolic processes and influence the prognosis of GC patients by mediating the level of m6A modification and protein expression, suggesting that these differentially expressed genes may serve as novel prognostic markers for GC patients.